
R&D
Exo-siR · Exo-Pro · Exo-Chem
Our target-loaded EVs have a high potential to be applied for infinite pipelines depending on the source of EVs (cell-derived, food-derived, or bacteria-derived) and cargo materials (siRNA, protein, chemical, etc.).
Target-loaded EVs are classified into Exo-siR (siRNA-loaded EV), Exo-Pro (protein-loaded EV), and Exo-Chem (chemical-loaded EV) according to the type of target loaded.
Exo-siR
siRNA-loaded EV
Exo-Pro
Protein-loaded EV
Exo-Chem
Chemical-loaded EV
Pipelines
The SWEET™ platform helps you develop potential treatments for unmet, high-demand diseases.
PDAC: pancreatic ductal adenocarcinoma · CRC: colorectal cancer · IBD: inflammatory bowel disease
KRAS siRNA-Loaded EV
- 2024.04Non-clinical efficacy confirmed (BioSpectator)
- 2024.03Preclinical results presented at AACR 2024
- 2023.12Selected for the KDDF candidate derivation program
